GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » EV-to-EBIT

Metagenomi (Metagenomi) EV-to-EBIT : 0.48 (As of May. 26, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Metagenomi EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Metagenomi's Enterprise Value is $-33.95 Mil. Metagenomi's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-71.32 Mil. Therefore, Metagenomi's EV-to-EBIT for today is 0.48.

The historical rank and industry rank for Metagenomi's EV-to-EBIT or its related term are showing as below:

MGX' s EV-to-EBIT Range Over the Past 10 Years
Min: -3.9   Med: -0.81   Max: 2.04
Current: 0.48

During the past 3 years, the highest EV-to-EBIT of Metagenomi was 2.04. The lowest was -3.90. And the median was -0.81.

MGX's EV-to-EBIT is ranked better than
80.28% of 426 companies
in the Biotechnology industry
Industry Median: 10.295 vs MGX: 0.48

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Metagenomi's Enterprise Value for the quarter that ended in Mar. 2024 was $115.95 Mil. Metagenomi's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-71.32 Mil. Metagenomi's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -61.51%.


Metagenomi EV-to-EBIT Historical Data

The historical data trend for Metagenomi's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metagenomi EV-to-EBIT Chart

Metagenomi Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBIT
- - -

Metagenomi Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only - - - - -1.63

Competitive Comparison of Metagenomi's EV-to-EBIT

For the Biotechnology subindustry, Metagenomi's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Metagenomi's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Metagenomi's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Metagenomi's EV-to-EBIT falls into.



Metagenomi EV-to-EBIT Calculation

Metagenomi's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-33.952/-71.322
=0.48

Metagenomi's current Enterprise Value is $-33.95 Mil.
Metagenomi's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-71.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Metagenomi  (NAS:MGX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Metagenomi's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=-71.322/115.945455
=-61.51 %

Metagenomi's Enterprise Value for the quarter that ended in Mar. 2024 was $115.95 Mil.
Metagenomi's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-71.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Metagenomi EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Metagenomi's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Metagenomi (Metagenomi) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Website

Metagenomi (Metagenomi) Headlines